Brusco Alfredo, Gellera Cinzia, Cagnoli Claudia, Saluto Alessandro, Castucci Alessia, Michielotto Chiara, Fetoni Vincenza, Mariotti Caterina, Migone Nicola, Di Donato Stefano, Taroni Franco
Dipartimento di Genetica, Biologia e Biochimica, Università di Torino and Unitá Operativa Genetica Medica, Ospedale San Giovanni Battista di Torino, Torino, Italy.
Arch Neurol. 2004 May;61(5):727-33. doi: 10.1001/archneur.61.5.727.
Autosomal dominant cerebellar ataxias are a clinical and genetically heterogeneous group of progressive neurodegenerative diseases, at present associated with 22 loci (spinocerebellar ataxia [SCA] 1-SCA8, SCA10-SCA19, SCA21, SCA22, fibroblast growth factor 14 [FGF14]-SCA, and dentatorubral-pallidoluysian atrophy [DRPLA]). The relevant gene has been identified in 12 cases (SCA1-3, SCA6-8, SCA10, SCA12, FGF14, and DRPLA), and in all but the recently identified SCA14, SCA17, PRKCG and FGF14 genes, the defect consists of the expansion of a short nucleotide repeat.
To investigate the relative prevalence of SCA1-3, SCA6-8, SCA10, SCA12, and SCA17 gene expansions in Italian families with hereditary ataxia, specifically to verify the occurrence of SCA10, SCA12, and SCA17 in Italy; and to analyze samples from probands with negative test results at the initial screening by means of the repeat expansion detection technique to identify CAG/CTG expansions in novel loci.Patients Two hundred twenty-five unrelated Italian index cases with hereditary ataxia, most (n = 183) of whom presented with a clear dominantly transmitted trait.
We found that SCA1 and SCA2 gene mutations accounted for most cases (21% and 24%, respectively). We found SCA3, SCA6, SCA7, SCA8, and SCA17 to be very rare (approximately 1% each), and no case of SCA10 or SCA12 was identified. Half of the index cases (113/225) were negative for expansions in the known SCA genes. Repeat expansion detection analysis performed on 111 of these cases showed a CAG/CTG repeat expansion of at least 50 triplets in 22 (20%). Twenty-one of 22 expansions could be attributed to length variation at 2 polymorphic loci (expanded repeat domain CAG/CTG 1 [ERDA1] or CTG repeat on chromosome 18q21.1 [CTG18.1]). In 1 patient, the expansion was assigned to the DRPLA gene.
The distribution of SCA1-3 and SCA6-7 gene mutations is peculiar in Italy. We found a relatively high frequency of SCA1 and SCA2 gene expansions; SCA3, SCA6, and SCA7 mutations were rare, compared with other European countries. No SCA10 or SCA12 and only a few SCA8 (2/225) and SCA17 (2/225) families were detected. In patients negative for defects in known SCA genes, repeat expansion detection data strongly suggest that, at least in our population, CAG/CTG expansions in novel genes should be considered an unlikely cause of the SCA phenotype.
常染色体显性遗传性小脑共济失调是一组临床和遗传异质性的进行性神经退行性疾病,目前与22个基因座相关(脊髓小脑共济失调[SCA]1 - SCA8、SCA10 - SCA19、SCA21、SCA22、成纤维细胞生长因子14[FGF14] - SCA以及齿状核红核苍白球路易体萎缩症[DRPLA])。12种情况(SCA1 - 3、SCA6 - 8、SCA10、SCA12、FGF14和DRPLA)的相关基因已被确定,除了最近确定的SCA14、SCA17、PRKCG和FGF14基因外,所有基因缺陷均由短核苷酸重复序列的扩增构成。
调查意大利遗传性共济失调家族中SCA1 - 3、SCA6 - 8、SCA10、SCA12和SCA17基因扩增的相对患病率,尤其要核实SCA10、SCA12和SCA17在意大利的发病情况;并通过重复序列扩增检测技术对初始筛查结果为阴性的先证者样本进行分析,以鉴定新基因座中的CAG/CTG扩增。
225例无亲缘关系的意大利遗传性共济失调索引病例,其中大多数(n = 183)呈现明显的显性遗传特征。
我们发现SCA1和SCA2基因突变占大多数病例(分别为21%和24%)。我们发现SCA3、SCA6、SCA7、SCA8和SCA17非常罕见(每种约1%),未发现SCA10或SCA12病例。一半的索引病例(113/225)在已知SCA基因中扩增为阴性。对其中111例病例进行的重复序列扩增检测分析显示,22例(20%)至少有50个三联体的CAG/CTG重复序列扩增。22个扩增中有21个可归因于2个多态性基因座的长度变异(扩增重复结构域CAG/CTG 1[ERDA1]或18号染色体q21.1上的CTG重复序列[CTG18.1])。在1例患者中,扩增被归因于DRPLA基因。
SCA1 - 3和SCA6 - 7基因突变在意大利的分布情况较为特殊。我们发现SCA1和SCA2基因扩增的频率相对较高;与其他欧洲国家相比,SCA3、SCA6和SCA7突变较为罕见。未检测到SCA10或SCA12,仅检测到少数SCA8(2/225)和SCA17(2/225)家族。在已知SCA基因缺陷为阴性的患者中,重复序列扩增检测数据强烈表明,至少在我们的人群中,新基因中的CAG/CTG扩增不太可能是SCA表型的病因。